AR026244A1 - Compuestos - Google Patents
CompuestosInfo
- Publication number
- AR026244A1 AR026244A1 ARP000105622A ARP000105622A AR026244A1 AR 026244 A1 AR026244 A1 AR 026244A1 AR P000105622 A ARP000105622 A AR P000105622A AR P000105622 A ARP000105622 A AR P000105622A AR 026244 A1 AR026244 A1 AR 026244A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- naphthylmethyl
- isopropyl
- butyl
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Un compuesto de formula (1) donde: R es isopropilo; n es O; R1 es naftilmetilo; R2 es t-butilo; y R3 es metilo; es util en el tratamiento de trastornosmediados por s-CD23.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9925470.8A GB9925470D0 (en) | 1999-10-27 | 1999-10-27 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AR026244A1 true AR026244A1 (es) | 2003-02-05 |
Family
ID=10863507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000105622A AR026244A1 (es) | 1999-10-27 | 2000-10-25 | Compuestos |
Country Status (32)
Country | Link |
---|---|
US (2) | US6673965B1 (es) |
EP (1) | EP1224164B1 (es) |
JP (1) | JP3922431B2 (es) |
KR (1) | KR20020044578A (es) |
CN (1) | CN1182107C (es) |
AR (1) | AR026244A1 (es) |
AT (1) | ATE284382T1 (es) |
AU (1) | AU766072B2 (es) |
BR (1) | BR0015082A (es) |
CA (1) | CA2389319A1 (es) |
CO (1) | CO5261576A1 (es) |
CZ (1) | CZ20021424A3 (es) |
DE (1) | DE60016622T2 (es) |
DK (1) | DK1224164T3 (es) |
ES (1) | ES2233474T3 (es) |
GB (1) | GB9925470D0 (es) |
GC (1) | GC0000142A (es) |
HK (1) | HK1049146A1 (es) |
HU (1) | HUP0203270A3 (es) |
IL (1) | IL149364A0 (es) |
MX (1) | MXPA02004228A (es) |
MY (1) | MY133601A (es) |
NO (1) | NO20021965L (es) |
NZ (1) | NZ518566A (es) |
PE (1) | PE20010898A1 (es) |
PL (1) | PL356524A1 (es) |
PT (1) | PT1224164E (es) |
SI (1) | SI1224164T1 (es) |
TW (1) | TW561141B (es) |
UY (1) | UY26416A1 (es) |
WO (1) | WO2001030747A1 (es) |
ZA (1) | ZA200203255B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2735929C (en) | 2008-09-19 | 2013-12-17 | Pfizer Inc. | Hydroxamic acid derivatives useful as antibacterial agents |
JP5836968B2 (ja) | 2009-12-01 | 2015-12-24 | ボストン メディカル センター コーポレーション | IgE媒介性疾患の処置方法 |
PL2512474T3 (pl) | 2009-12-16 | 2015-03-31 | Pfizer | N-przyłączone pochodne kwasu hydroksamowego użyteczne jako środki przeciwbakteryjne |
UA107423C2 (en) | 2011-03-07 | 2014-12-25 | Pfizer | Fluoro-pyridinone derivatives useful as antibacterial agents |
DK2694488T3 (en) | 2011-04-08 | 2014-12-15 | Pfizer | Isoxazole derivatives useful as antibacterial SUBSTANCES |
SG193458A1 (en) | 2011-04-08 | 2013-10-30 | Pfizer | Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents |
EP2525213A1 (en) * | 2011-05-16 | 2012-11-21 | Renishaw plc | Spectroscopic apparatus and methods for determining components present in a sample |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9513331D0 (en) | 1995-06-30 | 1995-09-06 | British Biotech Pharm | Matrix metalloproteinase inhibitors |
GB9813451D0 (en) * | 1998-06-22 | 1998-08-19 | Smithkline Beecham Plc | Novel compounds |
-
1999
- 1999-10-27 GB GBGB9925470.8A patent/GB9925470D0/en not_active Ceased
-
2000
- 2000-10-25 KR KR1020027005340A patent/KR20020044578A/ko not_active Application Discontinuation
- 2000-10-25 WO PCT/EP2000/010649 patent/WO2001030747A1/en active IP Right Grant
- 2000-10-25 JP JP2001533102A patent/JP3922431B2/ja not_active Expired - Fee Related
- 2000-10-25 GC GCP2000972 patent/GC0000142A/xx active
- 2000-10-25 BR BR0015082-7A patent/BR0015082A/pt not_active IP Right Cessation
- 2000-10-25 CZ CZ20021424A patent/CZ20021424A3/cs unknown
- 2000-10-25 DK DK00975954T patent/DK1224164T3/da active
- 2000-10-25 CA CA002389319A patent/CA2389319A1/en not_active Abandoned
- 2000-10-25 UY UY26416A patent/UY26416A1/es not_active Application Discontinuation
- 2000-10-25 CN CNB008173680A patent/CN1182107C/zh not_active Expired - Fee Related
- 2000-10-25 AR ARP000105622A patent/AR026244A1/es not_active Application Discontinuation
- 2000-10-25 US US10/111,209 patent/US6673965B1/en not_active Expired - Fee Related
- 2000-10-25 DE DE60016622T patent/DE60016622T2/de not_active Expired - Lifetime
- 2000-10-25 IL IL14936400A patent/IL149364A0/xx unknown
- 2000-10-25 EP EP00975954A patent/EP1224164B1/en not_active Expired - Lifetime
- 2000-10-25 NZ NZ518566A patent/NZ518566A/en unknown
- 2000-10-25 MX MXPA02004228A patent/MXPA02004228A/es active IP Right Grant
- 2000-10-25 MY MYPI20005012A patent/MY133601A/en unknown
- 2000-10-25 SI SI200030603T patent/SI1224164T1/xx unknown
- 2000-10-25 HU HU0203270A patent/HUP0203270A3/hu unknown
- 2000-10-25 PL PL00356524A patent/PL356524A1/xx unknown
- 2000-10-25 ES ES00975954T patent/ES2233474T3/es not_active Expired - Lifetime
- 2000-10-25 PT PT00975954T patent/PT1224164E/pt unknown
- 2000-10-25 AT AT00975954T patent/ATE284382T1/de not_active IP Right Cessation
- 2000-10-25 AU AU13895/01A patent/AU766072B2/en not_active Ceased
- 2000-10-26 CO CO00081571A patent/CO5261576A1/es not_active Application Discontinuation
- 2000-10-26 TW TW089122497A patent/TW561141B/zh active
- 2000-10-27 PE PE2000001156A patent/PE20010898A1/es not_active Application Discontinuation
-
2002
- 2002-04-24 ZA ZA200203255A patent/ZA200203255B/en unknown
- 2002-04-25 NO NO20021965A patent/NO20021965L/no unknown
- 2002-12-19 HK HK02109235A patent/HK1049146A1/xx not_active IP Right Cessation
-
2003
- 2003-10-03 US US10/678,679 patent/US20040077727A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE487493T1 (de) | Azolsäure-derivate, allein oder kombiniert, zur behandlung von diabetes und dyslipidaemien; und zur behandlung von malignen erkrankungen | |
ATE346039T1 (de) | Sulfonamido-substituierte verbrückte bicycloalkylderivative | |
GB9801690D0 (en) | Therapeutic agents | |
ATE287096T1 (de) | Elektrochrome vorrichtung | |
DK1193270T3 (da) | Pyrrolobenzodiazepiner | |
CY1111867T1 (el) | Ενωση ενεργοποιησης ppar και φαρμακευτικη συνθεση που περιεχει αυτη | |
TW200510441A (en) | Novel compounds | |
IS6309A (is) | Kínasólínafleiður | |
PE20040728A1 (es) | Inhibidores de caspasa | |
ATE377001T1 (de) | Pleuromutilinderivate als antimikrobielle mittel | |
MXPA05007296A (es) | Compuestos de (2-carboxamido)(3-amino)tiofeno. | |
ATE316962T1 (de) | Pyrimidin-derivate als selective inhibitoren von cox-2 | |
NZ516525A (en) | Orally active androgens | |
ATE402175T1 (de) | 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1, - naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren | |
DE60221508D1 (de) | Aminosäurederivate als hiv-protease-inhibitoren | |
ID23053A (id) | Karboksamida yang digunakan sebagai agonis 5-ht <if> | |
ATE273970T1 (de) | N-acyl und n-aroyl aralkylamide | |
AR026244A1 (es) | Compuestos | |
UA83266C2 (en) | Oxazole derivatives of tetracyclines | |
ATE270273T1 (de) | Substituierte azetidinone als entzüngdungshemmende und antidegenerative wirkstoffe | |
DE60121048D1 (de) | PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE | |
DE69837597D1 (de) | 4-Organothio-2-Cyclopentenonen und 3-Organothio-2-Cyclopentanonen, deren Herstellungsverfahren und pharmazeutischen Anwendungen | |
ATE286887T1 (de) | Antibakterielle mittel | |
AP2002002595A0 (en) | Heterocyclic amide derivatives. | |
DE60013515D1 (de) | 4-Arylpiperidinderivate zur Behandlung von Pruritus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |